TY - JOUR
T1 - In vitro transcription and translation of the human 1,25-dihydroxyvitamin D3 receptor cDNA
AU - Terpening, Christopher M.
AU - Haussler, Mark R.
N1 - Funding Information:
The work herein was supported by NIH grants DK-33351 and AR-15781, and is part
PY - 1990/12/31
Y1 - 1990/12/31
N2 - A fragment of the complementary deoxyribonucleic acid to the human 1,25-dihydroxyvitamin D3 receptor protein containing essentially the entire open reading frame was transcribed and translated in vitro. The resulting protein was then demonstrated to exhibit the physical and functional features, i.e. molecular weight, immunoreactivity, 1,25-dihydroxyvitamin D3 binding, and DNA-cellulose binding, of the native human receptor from the T47D cell line. This validates the authenticity of the cDNA in a cell free system and provides a biochemical means of generating this rare and labile macromolecule to use in heretofore difficult structure/function studies.
AB - A fragment of the complementary deoxyribonucleic acid to the human 1,25-dihydroxyvitamin D3 receptor protein containing essentially the entire open reading frame was transcribed and translated in vitro. The resulting protein was then demonstrated to exhibit the physical and functional features, i.e. molecular weight, immunoreactivity, 1,25-dihydroxyvitamin D3 binding, and DNA-cellulose binding, of the native human receptor from the T47D cell line. This validates the authenticity of the cDNA in a cell free system and provides a biochemical means of generating this rare and labile macromolecule to use in heretofore difficult structure/function studies.
UR - http://www.scopus.com/inward/record.url?scp=0025542993&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025542993&partnerID=8YFLogxK
U2 - 10.1016/S0006-291X(05)80903-9
DO - 10.1016/S0006-291X(05)80903-9
M3 - Article
C2 - 2176484
AN - SCOPUS:0025542993
SN - 0006-291X
VL - 173
SP - 1129
EP - 1136
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 3
ER -